Hereditary Angioedema Types I and II - 7 Studies Found
Active, not recruiting |
: A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema : Hereditary Angioedema Types I and II : 2014-12-10 : Biological: C1-esterase inhibitor |
Completed |
: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema : Hereditary Angioedema Types I and II : 2013-07-29 :
|
Recruiting |
: Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema : Hereditary Angioedema Types I and II : 2013-04-04 : Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc |
Completed |
: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor : Hereditary Angioedema Types I and II : 2012-12-24 :
|
Completed |
: A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route : Hereditary Angioedema Types I and II : 2012-04-10 :
|
Completed |
: Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert : Hereditary Angioedema Types I and II : 2011-11-07 : Biological: Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection |
Completed |
: Kinetics, Efficacy and Safety of C1-Esteraseremmer-N :
: 2005-07-04 : Drug: C1 inhibitor concentrate |